Drug
Talampanel
Talampanel: highest development phase Phase 2, developed by Teva. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Talampanel NCT00034814 | Phase 2 | Epilepsy |
| talampanel NCT00036296 | Phase 1/2 | Dyskinesias |
Latest
No recent events.
Follow Talampanel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.